Two Issued US Patents Granted to Cellectis for CRISPR Use in T-Cells – Business Wire (press release)
Business Wire (press release) |
Two Issued US Patents Granted to Cellectis for CRISPR Use in T-Cells
Business Wire (press release) Convinced of their strong value for the future development of engineered CAR T-cells, Cellectis will make these patents available for licensing to companies that are willing to use CRISPR technologies in T-cells. The technical knowledge in these … France's Cellectis wins US patents for gene editing technology |
